Dermatologic NOA-104 ameliorates atopic dermatitis in the preclinical setting March 20, 2025 Atopic dermatitis (AD) is mainly triggered by immune dysregulation, barrier dysfunction and inflammation propagation, and chronic itching increases the susceptibility to infections.Read More